期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

血管内皮生长因子-C和血管内皮生长因子受体-3在侵袭性甲状腺乳头状癌中的表达及意义 被引量：5

The expression of VEGF-C and VEGFR3 in invasive papillary thyroid carcinoma and its significance
原文传递
导出
摘要 目的观察血管内皮生长因子（VEGF—C）和血管内皮生长因子受体（VEGFR5）在侵袭性甲状腺乳头状癌组织中的表达，探讨甲状腺乳头状癌细胞淋巴管转移机理。方法用免疫组化方法检测VEGF—C和VEGFR3在人侵袭性甲状腺乳头状癌和非侵袭性甲状腺乳头状癌中的表达情况，并进行比较和分析。结果在侵袭性和非侵袭性甲状腺乳头状癌中均可见到VEGF—C和VEGFR3阳性表达，但在侵袭性甲状腺乳头状癌组织VEGF—C（χ2=4．738，P=0．030）和VEGFR3（χ2=11．951，P=0．010）的表达率和表达强度均高于非侵袭性甲状腺乳头状癌。结论VEGF—C和VEGFR3在侵袭性甲状腺乳头状癌细胞中高表达，并且可能与此肿瘤的侵袭性相关。 Objective The expression of vasular endothethlial a growth factors receptor（VEGF） -C and vascular endothe thlial growth factors receptor（VEGFR） 3 was observed in invasive papillary thyroid carcinoma in order to elucidate the mechanism of lymphatic metastasis of cancer cell. Methods The expression of VEGF- C and VEGFR3 in invasive and noninvasive papillary thyroid carcinoma was examined by immunohistochemical staining for comparison and analysis. Results Both VEGF-C （χ2 = 4. 738,P = 0.03 ） and VEGFR3 （χ2 = 11. 951 ,P =0. 01 ）expressed in invasive and noninvasive papillary thyroid carcinoma but were highly expressed in invasive papillary thyroid carcinoma. Conclusion The VEGF-C and VEGFR3 were highly expressed in invasire papillary thyroid carcinoma and perhaps have correlation with the invasiveness of cancer.
作者 李传乐 张滨
机构地区 哈尔滨医科大学第二临床医学院普外四科
出处 《国际免疫学杂志》 CAS 2012年第2期157-159,共3页 International Journal of Immunology
基金 哈尔滨医科大学第二临床医院博士启动基金项目（BS2007-18）
关键词 甲状腺乳头状癌 血管内皮生长因子-C 血管内皮生长因子受体-3 免疫组化 Papillary thyroid carcinoma VEGF-C VEGFR3 Immunohistochemistry
分类号 R736.1 [医药卫生—肿瘤]
  • 相关文献

参考文献8

  • 1Sharma PS, Sharnaa R, Tyagi T. VEGF/VEGFR pathway inhibitors as anti-angiagenic agents: present and future. Curt Cancer Drug Targets, 2011,11 ( 5 ) : 624 -653.
  • 2Nykanen A1, Sandelin H, Krebs R, et al. Targeting lymphatic vessel activation and CCL21 production by vascular endothelial growth factor receptor-3 inhibition has novel immunomodulatory and anti- arteriosclerotic effects in cardiac allografts. Circulation,2010,121 (12) :1413-1422.
  • 3Kaipainen A, Korhonen J, Mustonen T, et al. Expression of the fms-like tyrosine kinase FLT4 gene becomes restricted to endothelium of lymphatic vessels during development. Proc Natl Acad Sci U S A, 1995,92(8) :3566-3570.
  • 4骆华杰,李吉平,杨腾飞,王家东.VEGF-C和VEGF-D在分化型甲状腺癌中的表达及意义[J].临床耳鼻咽喉头颈外科杂志,2009,23(12):531-534. 被引量：15
  • 5Fellmer P, Satork T, Tanka R,et al. Vascular endothelial growth factor C gene expression in papillary and follicaulr thyroid carcino- mas. surgery, 1999, 126(6): 1056-1061.
  • 6Haigh H, Urbach DR, Rotstein LE. AMES prognostic index and extent of thyroidectomy for well-differentiated thyroid cancer in the United States. Surgery,2004,136 (3) :609-616.
  • 7Hay ID, Bergstralh E J, Goellner JR, et al. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery, 1993, 114 ( 6 ) : 1050-1058.
  • 8Hung C J, Ginzinger DG, Zarnegar R, et al. Expression of vascular endothelial growth factor-C in benign and malignant thyroid tumors. J Clin Endocrinol Metab,2003,88 (8) :3694-3699.

二级参考文献12

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量：1365
  • 2王亚秋,华清泉.甲状腺乳头状癌中缺氧诱导因子-1α和血管内皮生长因子及血管内皮生长因子-C表达的临床意义[J].临床耳鼻咽喉头颈外科杂志,2007,21(5):204-206. 被引量：12
  • 3KRISHNAN J, KIRKIN V, STEFFEN A, et al. Differential invivo and invitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumor and its relationship to lymphatic metastasis in immunocompetentrats[J]. Cancer Res, 2003, 63: 713--722.
  • 4NAKASHIMA T, KONDOH S, KITOH H, et al. Vascular endothelial growth factor-C expression in human gallbladder cancer and its relationship to lymphodemetastasis[J]. Int J Mol Med, 2003,11 : 33 -- 39.
  • 5FELLMER P T, SATO K, TANAKA R, et al. Vascular endothelial growth factor C gene expression in papillary and follicular thyroid carcinomas[J]. Surgery,1999,126:1056--1061.
  • 6GERSHENWALD J E, FIDLER I J. Targeting lymphatic metastasis [J]. Science, 2002, 296:1811 -- 1812.
  • 7MANDRIOTA S J, JUSSILA L, JELTSCH M, et al. Vascular endothelial growth factor-C mediated lymphangiogenesis promotes tumor metastasis [J]. EMBO J,2001,20:672-682.
  • 8PAPOUTSI M, SIEMEISTER G, WEINDEL K, et al. Active interaction of human A375 melanoma cells with the lymphatics in vivo[J]. Histochem Cell Biol, 2000,114:373--385.
  • 9FUNAKI H, NISHIMURA G, HARADA S, et al. Expression of vascular endothelial growth factor D is associated with lymph node metastasis in human colorectal carcinoma[J]. Oncology,2003,64:416-422.
  • 10STACKER S A, CAESAR C, BALDWIN M E, et al. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics[J]. Nat Med, 2001,7 : 186 -- 191.

共引文献14

同被引文献55

  • 1孙占勇,程若川.甲状腺乳头状癌的发病特点及诊治现状[J].昆明医科大学学报,2012,33(S1):113-115. 被引量：5
  • 2赵亚萍,王鑫.甲状腺乳头状癌的超声图像特征与病理分析[J].医学影像学杂志,2012,22(2):274-275. 被引量：11
  • 3Lee SH,Lee SJ,Jin SM. Relationships between lymph node metastasis and expression of CD31,D2-40,and vascular endothelial growth factors A and C in papillary thyroid cancer[J].Clin Exp Otorhinolaryngol,2012,(3):150-155.
  • 4Yasuoka H,Kodama R,Hirokawa M. Neuropilin-2 expression in papillary thyroid carcinoma:correlation with VEGF D expression,lymph node metastasis,and VEGF-D-induced aggressive cancer cell phenotype[J].{H}Journal of Clinical Endocrinology and Metabolism,2011,(11):E1857-E1861.
  • 5Karkkainen MJ,Ferrell RE,Lawrence EC. Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema[J].{H}Nature genetics,2000,(2):153-159.
  • 6Eloy C,Santos J,Soares P. Intratumoural lymph vessel density is related to presence of lymph node metastases and separates encapsulated from infiltrative papillary thyroid carcinoma[J].{H}VIRCHOWS ARCHIV-AN INTERNATIONAL Journal OF PATHOLOGY,2011,(6):595-605.
  • 7Widodo I,Ferronika P,Harijadi A. Clinicopathological significance of lymphangiogenesis and tumor lymphovascular invasion in indonesian breast cancers[J].Asian Pacific J Cancer Prev,2013,(2):997-1001.
  • 8Su JL,Yen CJ,Chen PS. The role of the VEGF-C/VEGFR3 axis in cancer progression[J].{H}British Journal of Cancer,2007,(4):541-545.
  • 9Chung MK,Kim JH,Ko YH. Correlation of lymphatic vessel density and vascular Endothelial growth factor with nodal metastasis in papillary thyroid microcarcinoma[J].{H}Head & Neck,2012,(6):846-851.
  • 10Choi Y,Park KJ,Ryu S. Papillary thyroid carcinoma involving cervical neck lymph nodes:correlations with lymphangio genesis and ultrasound features[J].{H}ENDOCRINE JOURNAL,2012,(10):941948.

引证文献5

二级引证文献13

国际免疫学杂志
2012年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部